The United States Food and Drug Administration (USFDA) has inspected one of the Manufacturing facilities of Neuland Laboratories (Unit 2), located at Pashmylaram, Patancheru Mandal, Sangareddy District in the state of Telangana, from November 26-29, 2018. The inspection at Unit 2 by the USFDA has been successfully completed, with no observations under Form 483.
Neuland Laboratories manufactures active pharmaceutical ingredients for global pharmaceutical companies and provides end-to-end solutions for the pharmaceutical industry for chemistry-related services.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.
